Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioharvest Sciences Inc BHST


Primary Symbol: C.BHSC

BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.


CSE:BHSC - Post by User

Post by NoRetireon Mar 25, 2022 1:48pm
161 Views
Post# 34546249

Stock options granted

Stock options granted

VANCOUVER, BC, March 25, 2022 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC)announces that it has granted a total of 482,000 stock options to consultants and employees. The stock options granted are exercisable to purchase a common share of the Company at a price of $0.35 per share for a term of 10 years.

The 482,000 stock options granted will vest as follow: 240,000 stock vesting quarterly over a 3-year period, 215,000 vesting quarterly over a 1-year period, 12,000 vesting monthly over a 6-month period and 15,000 vesting monthly over a 4-month period.

<< Previous
Bullboard Posts
Next >>